The Hill15d
FDA approves Zepbound for sleep apnea in obese adults
Sleep apnea causes people to stop and start breathing repeatedly Zepbound is first drug approved by FDA to help treat it Two studies found that those who used it saw reduction in apnea events ...
Yahoo News Australia15d
FDA approves Zepbound for sleep apnea in obese adults
(NewsNation) — Zepbound became the first drug approved by the Food and Drug Administration to treat obstructive sleep apnea in obese adults earlier this month. “This is a major step forward ...
Hosted on MSN17d
Weight loss drug Zepbound approved to treat sleep apnea
Clinical research by Zepbound's manufacturer Eli Lilley found that the drug's active ingredient tirzepatide reduces sleep apnea by about 60%. I've been on 50 cruises. Here are 5 things I never buy ...
The Hindu18d
IIT Bombay researchers develop painless needle-free shock syringes
In a welcome move for many patients who have a fear of needles, latest research by the ... is slightly longer than a regular ballpoint pen. The device has a micro shock tube consisting of three ...
Everyday Health18d
FDA Approves First Medication for Obstructive Sleep Apnea
The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...
Renal & Urology News19d
Zepbound Approved for Obstructive Sleep Apnea in Patients With Obesity
The Food and Drug Administration (FDA) has approved Zepbound ® (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea (OSA) in adults with obesity. Zepbound is a dual ...
People19d
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Patients taking a compounded alternative to Eli Lilly's weight loss drug Zepbound will need to transition to the name-brand version in early 2025 Charlotte Phillipp is a Weekend Writer-Reporter at ...
KSL19d
Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep apnea
WASHINGTON — The U.S. Food and Drug Administration on Friday approved Eli Lilly's weight-loss treatment, Zepbound, for obstructive sleep apnea, making it the first drug to get the green light to ...
Yahoo Style UK19d
The Zepbound Shortage Is Over — Here's What to Expect if You've Been Using an Off-Brand Version
Shelby Knowles/Bloomberg via Getty A Zepbound injection pen. The FDA has also cited overdoses as a concern, as it has received reports of patients giving themselves the incorrect dose of off-brand ...
The Spokesman-Review20d
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the ...
New York Post20d
FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound (tirzepatide) to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity. The drug is to be ...
People21d
Zepbound Weight Loss Medication Approved by FDA to Treat Sleep Apnea
Shelby Knowles/Bloomberg via Getty The weight loss drug Zepbound, generically known as tirzepatide, is also now an approved medication to treat obstructive sleep apnea, per a Food and Drug ...